|
(Mark One)
|
|
|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the fiscal year ended December 31, 2017
|
|
|
|
or
|
|
|
|
|
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from _____________to ______________
|
Texas
|
75-2095676
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
Title of each class
|
Name of each exchange on which registered
|
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
||
Non-accelerated filer ☐ (Do not check if a smaller reporting company)
|
|
Smaller reporting company ☒
|
||
Emerging growth company r
|
|
|
PART I.
|
PAGE
|
|
|
|
|
Item 1.
|
3
|
|
Item 1A.
|
7
|
|
Item 1B.
|
7
|
|
Item 2.
|
7
|
|
Item 3.
|
7
|
|
Item 4.
|
7
|
|
|
|
|
PART II.
|
|
|
|
|
|
Item 5.
|
8
|
|
Item 6.
|
9
|
|
Item 7.
|
9
|
|
Item 7A.
|
16
|
|
Item 8.
|
16
|
|
Item 9.
|
16
|
|
Item 9A (T).
|
16
|
|
Item 9B.
|
17
|
|
|
|
|
PART III.
|
|
|
|
|
|
Item 10.
|
18
|
|
Item 11.
|
20
|
|
Item 12.
|
22
|
|
Item 13.
|
23
|
|
Item 14.
|
24
|
|
|
|
|
PART IV.
|
|
|
|
|
|
Item 15.
|
25
|
|
|
|
|
|
26
|
|
Closing Prices
|
|||||||
|
High
|
Low
|
||||||
Quarters ending in 2016
|
||||||||
March 31
|
$
|
2.34
|
$
|
0.28
|
||||
June 30
|
$
|
2.50
|
$
|
1.20
|
||||
September 30
|
$
|
1.90
|
$
|
1.41
|
||||
December 31
|
$
|
2.50
|
$
|
0.15
|
||||
Quarters ending in 2017
|
||||||||
March 31
|
$
|
2.00
|
$
|
1.30
|
||||
June 30
|
$
|
1.75
|
$
|
1.07
|
||||
September 30
|
$
|
1.29
|
$
|
0.53
|
||||
December 31
|
$
|
0.59
|
$
|
0.34
|
Plan Description at December 31, 2017 and 2016
|
Number of Shares to be Issued Upon Exercise of
Outstanding Options
|
Weighted Average Exercise Price of Outstanding Options
|
Number of Shares Remaining Available for Future Issuance
|
|||||||||
Initial Number of Securities Available for Issue Under the Plan
|
1,000,000
|
|||||||||||
Total Equity Plan Options outstanding at December 31, 2015 (1)
|
90,000
|
$
|
0.34
|
4,243,072
|
||||||||
Total options approved and issued in 2016
|
-
|
-
|
-
|
|||||||||
Options exercised by holders in 2016
|
15,000
|
-
|
-
|
|||||||||
Total Equity Plan Options outstanding at December 31, 2016 (2)
|
75,000
|
$
|
0.41
|
*-
|
||||||||
Total options approved and issued in 2017
|
-
|
-
|
-
|
|||||||||
Options expired in 2017
|
10,000
|
-
|
-
|
|||||||||
Total Equity Plan Options outstanding at December 31, 2017 (3)
|
65,000
|
$
|
0.35
|
*-
|
(1) |
The number of Options issued and exercised under the Plan in the years 2007 through 2016 and the increases in securities added to the Plan* for each year are as follows:
|
Year
|
|
Options Granted
|
|
|
Options Forfeited or Exercised
|
|
|
|
Securities added to Plan
|
|
|
Securities available*
at December 31st
|
|
||||
2007
|
|
|
155,000
|
|
|
|
-0-
|
|
|
|
|
-0-
|
|
|
|
845,000
|
|
2008
|
|
|
240,000
|
|
|
|
-0-
|
|
|
|
|
479,900
|
|
|
|
1,084,900
|
|
2009
|
|
|
195,000
|
|
|
|
-0-
|
|
|
|
|
482,500
|
|
|
|
1,372,400
|
|
2010
|
|
|
145,000
|
|
|
|
(255,000
|
)
|
|
|
|
483,300
|
|
|
|
1,965,700
|
|
2011
|
|
|
-0-
|
|
|
|
(390,000
|
)
|
|
|
|
462,500
|
|
|
|
2,818,200
|
|
2012
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
|
462,500
|
|
|
|
3,280,700
|
|
2013
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
|
462,500
|
|
|
|
3,743,200
|
|
2014
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
|
499,872
|
|
|
|
4,243,072
|
|
2015
|
|
|
-0-
|
|
|
|
-0-
|
|
|
|
|
*
|
|
|
|
*
|
|
2016
|
|
|
-0-
|
|
|
|
15,000
|
|
1
|
|
|
*
|
|
|
|
*
|
|
2017
|
|
|
-0-
|
|
|
|
10,000
|
|
2
|
|
|
*
|
|
|
|
*
|
|
(2) |
Of the 75,000 options still active as of December 31, 2016: (i) 10,000 expire at 11-2-2017; (ii) 15,000 expire at 12-31-2018; (iii) 30,000 expire at 11-6-2019; and, (iv) 20,000 expire at 12-23-2020.
|
(3) |
Of the 65,000 options still active as of December 31, 2017: (i) 15,000 expire at 12-31-2018; (ii) 30,000 expire at 11-6-2019; and, (iii) 20,000 expire at 12-23-2020.
|
a. |
Cannabis oil extraction and processing. MariJ Pharma has a unique mobile cannabis oil processing and extraction unit designed into a heavy-duty trucks. That unit has already begun performing extractions and processing of medical hemp oils at various sites and is currently developing additional contracts for services.
|
b. |
Wholesale sale of raw and processed medical cannabis oils.
|
c. |
Compounding and manufacturing. MariJ Pharma has begun construction of a mobile laboratory and testing unit, also on a heavy-duty truck chassis, intended to address the growing demand for these services in the medical cannabis industry.
|
d. |
Licensing and support of the Company’s GeoTraking Technology systems
|
e. |
Processing and compounding services for medical grade cannabis oils
|
1) |
EMT will seek to enter into product development projects with institutions of higher learning in efforts to develop new and better strains of medical cannabis related products for dispensing as medications, nutraceuticals, cosmeceuticals, and probably dietary supplements. EMT anticipates participating in state and federal grants in conjunction with one or more universities as a means to defray part of its costs in these efforts.
|
2) |
Private label packaging services - the Company has obtained a majority of the equipment required to engage in the business of packaging and labeling of medical cannabis oils, oil-infused products, and related items.
|
3) |
Retail sales of medical cannabis oils, oil-infused products, and other merchandise through its web-based portal or retail dispensaries planned for that purpose. These activities are dependent in large part upon meeting FDA regulations and criteria relating to the sale and distribution of cannabis-infused products, and the Company is currently in the process of determining the status of those criteria.
|
4) |
Retail, and wholesale distributor, sales of cosmeceutical and nutraceutical products and dietary supplements containing its high-quality cannabis oil extracts, subject to compliance with FDA and other regulations.
|
5) |
Growing high quality cannabis plants and extracting oil for sale or for manufacturing of oil-infused products.
|
Name
|
|
Age
|
|
Position
|
Richard K. Pertile
|
|
56
|
|
Director, President, Chairman of the Board, Chief Executive Officer and Chief Financial Officer
|
Danny R. Gibbs
|
|
60
|
|
Director
|
Neil Gholson
|
|
58
|
|
Director
|
Gary J. Roberts, Jr.
|
|
51
|
|
Director
|
Kim Edwards
|
|
50
|
|
Vice President and Chief Operating Officer
|
Name
|
Number of late reports
|
Number of transactions
not reported timely
|
||||
Richard K. Pertile, CEO and CFO
|
1
|
1
|
Director Name
|
|
Audit Committee
|
|
|
Compensation Committee
|
|
|
Nominating Committee
|
|
|
Primary Committee
|
|
Richard K. Pertile
|
|
—
|
|
|
—
|
|
|
Member
|
|
|
Member
|
|
Danny R. Gibbs
|
|
Chair
|
|
|
Member
|
|
|
Member
|
|
|
Member
|
|
Neil B. Gholson
|
|
Member
|
|
|
Chair
|
|
|
Chair
|
|
|
—
|
|
Gary J. Roberts, Jr.
|
|
Member
|
|
|
Member
|
|
|
—
|
|
|
Chair
|
|
|
|
Annual Compensation
|
||||||||||||
Name and Principal Position
|
Fiscal Year
|
Salary
|
Bonus
|
Total
|
||||||||||
Richard K. Pertile (1)
|
2017
|
$
|
195,000
|
$
|
68,250
|
$
|
263,250
|
|||||||
2016 |
$
|
170,000
|
$
|
59,500
|
$
|
229,500
|
||||||||
Kim Edwards (2)
|
2017
|
$
|
101,192
|
$
|
35,417
|
$
|
136,609
|
|||||||
2016 |
$
|
96,000
|
$
|
-
|
$
|
96,000
|
||||||||
Steven Sample, CEO (3)
|
2017
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
2016 |
$
|
195,000
|
$
|
48,000
|
$
|
243,000
|
|
|
Number of Securities Underlying Unexercised Options
|
|
|
Number of Securities Underlying Unexercised Options Unexercisable
|
|
|
Weighted Average Per Share Exercise Price
|
|
|
Expiration Dates
|
|
||||
None
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Dollar Amount Recognized for Financial Reporting Purposes
|
|||||||
|
2017
|
2016
|
||||||
Richard K. Pertile (1)
|
$
|
-0-
|
$
|
-0-
|
||||
Steven L. Sample (2)
|
-0-
|
-0-
|
||||||
Neil B. Gholson (3)(8)
|
33,000
|
-0-
|
||||||
Gary J. Roberts, Jr. (4)(8)
|
33,000
|
-0-
|
||||||
Danny Gibbs (5)(8)
|
33,000
|
-0-
|
||||||
V. Weldon Hewitt (6)
|
-0-
|
-0-
|
||||||
Dan L. Rigdon (7)
|
-0-
|
-0-
|
||||||
Total
|
$
|
99,000
|
$
|
-0-
|
(1) |
Appointed as Chairman of the Company’s Board of Directors January 15, 2016.
|
(2) |
Served as Chairman of the Company’s Board of Directors from August 2006 until January 15, 2016, at which time he continued to serve as a director until resigning on January 17, 2017.
|
(3) |
Appointed to the Company’s Board of Directors on January 15, 2016.
|
(4) |
Appointed to the Company’s Board of Directors on January 15, 2016.
|
(5) |
Originally served on the Company’s board of directors from 1984 through August of 2006. Was again appointed to the Board of Directors on February 1, 2007 where he served until September 29, 2011. Was reappointed to the Board of Directors on September 1, 2013 and continues to serve.
|
(6) |
Originally served on the Company’s board of directors from 1984 through August of 2006. Was again appointed to the Board of Directors on February 1, 2007 where he served until September 29, 2011. Was reappointed to the Board of Directors on September 1, 2013, and served until resigning January 15, 2016.
|
(7) |
Appointed to the Company’s Board of Directors on September 1, 2013, and served until resigning January 15, 2016.
|
(8) |
In the year ended December 31, 2017, each of these directors was issued 20,000 shares of the Company’s restricted common stock for services performed. These 60,000 shares were valued at $99,000 on commitment date. There was no cash compensation paid to the directors.
|
Shares Owned at December 31, 2017
|
|
|||||||
Name and Address of Beneficial Owner
|
|
Number of Shares
|
|
|
Percent
|
|
||
Richard K. Pertile (1)
|
|
|
4,944,000
|
|
|
|
28.20
|
%
|
Steven L. Sample (2)
|
|
|
1,659,290
|
|
|
|
9.47
|
%
|
Neil B. Gholson (3)
|
|
|
240,000
|
|
|
|
1.37
|
%
|
Gary J. Roberts, Jr. (4)
|
|
|
377,720
|
|
|
|
2.15
|
%
|
Danny R. Gibbs (5)
|
|
|
177,500
|
|
|
|
1.01
|
%
|
All directors and officers as a group (five persons)
|
|
|
7,398,510
|
|
|
|
42.20
|
%
|
All of the above as a group (five persons)
|
|
|
7,398,510
|
|
|
|
42.20
|
%
|
|
2017
|
2016
|
||||||
Audit fees
|
$
|
74,790
|
$
|
127,447
|
||||
Tax preparation fees
|
11,500
|
7,500
|
||||||
|
||||||||
Total fees
|
$
|
86,290
|
$
|
134,947
|
|
Page
|
F-2
|
|
F-3
|
|
F-4
|
|
F-5
|
|
F-6
|
|
F-7 to F-21
|
Exhibit Number and Description
|
|
Location Reference
|
|||
|
|
|
|
|
|
|
(3.0)
|
Articles of Incorporation
|
|
|
|
|
|
(3.1)
|
|
See Exhibit Key
|
|
|
|
(3.2)
|
|
See Exhibit Key
|
|
|
(9.0)
|
|
See Exhibit Key
|
||
|
(10.1)
|
|
See Exhibit Key
|
||
|
(10.2)
|
|
See Exhibit Key
|
||
|
(10.3)
|
|
See Exhibit Key
|
||
|
(10.4)
|
|
See Exhibit Key
|
||
|
(10.5)
|
|
See Exhibit Key
|
||
|
(10.6)
|
|
See Exhibit Key
|
||
|
(14.0)
|
|
See Exhibit Key
|
||
|
(21.0)
|
|
See Exhibit Key
|
||
|
(31.1)
|
|
Filed herewith
|
||
|
(32.1)
|
|
Filed herewith
|
||
|
101.INS
|
XBRL Instance Document
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
Acacia Diversified Holdings, Inc.
|
|||
Date: April 2, 2018
|
By:
|
/s/ Richard K. Pertile
|
|
Richard K. Pertile
|
|||
Chief Executive Officer, Chief Financial Officer, President, and Chairman of the Board
|
Signature
|
Title
|
Date
|
||
/s/ Richard K. Pertile
|
Director
|
April 2, 2018
|
||
Richard K. Pertile
|
/s/ Neil B. Gholson
|
Director
|
April 2, 2018
|
||
Neil B. Gholson
|
/s/ Gary J. Roberts, Jr.
|
Director
|
April 2, 2018
|
||
Gary J. Roberts, Jr.
|
/s/ Danny R. Gibbs
|
Director
|
April 2, 2018
|
||
Danny R. Gibbs
|
|
Page
|
|
|
F-2
|
|
|
|
F-3
|
|
|
|
F-4
|
|
|
|
F-5
|
|
|
|
F-6
|
|
|
|
F-7
|
|
2017
|
2016
|
||||||
ASSETS
|
||||||||
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
28,417
|
$
|
43,878
|
||||
Accounts receivable, net of allowance for doubtful accounts of
$17,450 and $0 in 2017 and 2016, respectively
|
22,820
|
35,630
|
||||||
Inventories
|
57,257
|
63,085
|
||||||
Prepaid expenses and other current assets
|
11,034
|
60,502
|
||||||
Total Current Assets
|
119,528
|
203,095
|
||||||
|
||||||||
PROPERTY AND EQUIPMENT,
net of accumulated depreciation of $172,783 and $108,886 in 2017 and 2016, respectively
|
483,931
|
480,847
|
||||||
|
||||||||
DEPOSITS
|
3,341
|
841
|
||||||
|
||||||||
TOTAL ASSETS
|
$
|
606,800
|
$
|
684,783
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||||||||
|
||||||||
CURRENT LIABILITY:
|
||||||||
Accounts payable and accrued expenses
|
$
|
452,710
|
$
|
390,530
|
||||
Note payable to related party
|
558,400
|
-
|
||||||
Payable to related parties
|
81,058
|
4,000
|
||||||
Total Current Liability
|
1,092,168
|
394,530
|
||||||
|
||||||||
Total Liabilities
|
1,092,168
|
394,530
|
||||||
|
||||||||
Commitments and contingencies
|
-
|
-
|
||||||
|
||||||||
STOCKHOLDERS’ EQUITY (DEFICIT)
|
||||||||
Common stock, $0.001 par value; 150,000,000 shares authorized; 17,539,982 and 16,931,816
shares issued and outstanding at December 31, 2017 and 2016, respectively
|
17,540
|
16,932
|
||||||
Additional paid-in capital
|
4,451,038
|
3,393,539
|
||||||
Accumulated deficit
|
(4,953,946
|
)
|
(3,120,218
|
)
|
||||
Total Stockholders’ Equity (Deficit)
|
(485,368
|
)
|
290,253
|
|||||
|
||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
$
|
606,800
|
$
|
684,783
|
|
2017
|
2016
|
||||||
|
||||||||
|
||||||||
REVENUE
|
$
|
478,231
|
$
|
311,283
|
||||
|
||||||||
COSTS OF GOODS SOLD
|
||||||||
Costs of goods sold
|
168,400
|
169,135
|
||||||
Depreciation expense
|
72,943
|
69,848
|
||||||
|
241,343
|
238,983
|
||||||
|
||||||||
GROSS PROFIT
|
236,888
|
72,300
|
||||||
|
||||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
|
||||||||
Employee compensation expenses
|
720,141
|
637,475
|
||||||
General and administrative expenses
|
909,230
|
1,169,932
|
||||||
Depreciation expense
|
5,514
|
7,012
|
||||||
|
1,634,885
|
1,814,419
|
||||||
|
||||||||
LOSS FROM OPERATIONS
|
(1,397,997
|
)
|
(1,742,119
|
)
|
||||
|
||||||||
OTHER INCOME (EXPENSE)
|
||||||||
Loss on sale of equipment to related party
|
-
|
(42,987
|
)
|
|||||
Loss on sale of equipment
|
(9,530
|
)
|
-
|
|||||
Interest expense
|
(427,572
|
)
|
(148
|
)
|
||||
Other income
|
1,371
|
140
|
||||||
TOTAL OTHER INCOME (EXPENSE)
|
(435,731
|
)
|
(42,995
|
)
|
||||
|
||||||||
NET LOSS BEFORE INCOME TAXES
|
$
|
(1,833,728
|
)
|
$
|
(1,785,114
|
)
|
||
Income taxes
|
-
|
-
|
||||||
|
||||||||
NET LOSS
|
$
|
(1,833,728
|
)
|
$
|
(1,785,114
|
)
|
||
|
||||||||
NET (LOSS) INCOME PER COMMON SHARE, BASIC AND DILUTED
|
$
|
(0.11
|
)
|
$
|
(0.11
|
)
|
||
|
||||||||
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING, BASIC AND DILUTED
|
17,372,858
|
15,548,247
|
|
Members Equity
|
Common Stock
|
||||||||||||||||||||||||||
|
Units
|
Amount
|
Shares
|
Par Value
|
Additional Paid-in Capital
|
Accumulated Deficit
|
Total
|
|||||||||||||||||||||
|
||||||||||||||||||||||||||||
Balance December 31, 2015
|
8,000
|
$
|
20,687
|
666,950
|
$
|
667
|
$
|
2,207,708
|
$
|
(1,335,104
|
)
|
$
|
893,958
|
|||||||||||||||
|
||||||||||||||||||||||||||||
Reverse merger and recapitalization
|
(8,000
|
)
|
(20,687
|
)
|
14,763,306
|
14,763
|
235,608
|
229,684
|
||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
-
|
-
|
15,430,256
|
15,430
|
2,443,316
|
(1,335,104
|
)
|
1,123,642
|
||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for exercise of options
|
15,000
|
15
|
135
|
150
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for services
|
156,560
|
157
|
286,418
|
|
286,575
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for related party payable
|
1,200,000
|
1,200
|
598,800
|
|
600,000
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for cash
|
130,000
|
130
|
64,870
|
|
65,000
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Net loss
|
(1,785,114
|
)
|
|
(1,785,114
|
)
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Balance December 31, 2016
|
-
|
|
-
|
16,931,816
|
|
16,932
|
|
3,393,539
|
|
(3,120,218
|
)
|
|
290,253
|
|||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for services
|
340,900
|
341
|
565,228
|
|
565,569
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued for interest expense
|
216,000
|
216
|
366,184
|
|
366,400
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Employee stock plan compensation
|
10,000
|
10
|
75,405
|
|
75,415
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Common stock issued to acquire property and equipment
|
41,266
|
41
|
50,682
|
|
50,723
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Net loss
|
(1,833,728
|
)
|
|
(1,833,728
|
)
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Balance December 31, 2017
|
-
|
$
|
-
|
17,539,982
|
$
|
17,540
|
$
|
4,451,038
|
$
|
(4,953,946
|
)
|
$
|
(485,368
|
)
|
|
2017
|
2016
|
||||||
|
||||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$
|
(1,833,728
|
)
|
$
|
(1,785,114
|
)
|
||
Adjustments to reconcile net loss to net cash and cash equivalents
used by operating activities:
|
||||||||
Depreciation
|
78,457
|
76,860
|
||||||
Common stock issued for services
|
565,569
|
286,575
|
||||||
Common stock issued from employee stock plan
|
75,415
|
-
|
||||||
Common stock issued for interest expense
|
366,400
|
-
|
||||||
Amortization of debt discount
|
20,950
|
-
|
||||||
Loss on sale of equipment
|
9,530
|
-
|
||||||
Allowance for doubtful accounts
|
17,450
|
-
|
||||||
Loss on sale of equipment to related party
|
-
|
42,987
|
||||||
(Increase) decrease in:
|
||||||||
Accounts receivable
|
(4,640
|
)
|
112,070
|
|||||
Inventories
|
5,828
|
(63,085
|
)
|
|||||
Prepaid expenses and other current assets
|
46,968
|
(33,422
|
)
|
|||||
Increase (decrease) in:
|
||||||||
Accounts payable and accrued expenses
|
85,530
|
371,243
|
||||||
Payable to related parties
|
78,494
|
4,000
|
||||||
Net cash used by operating activities
|
(487,777
|
)
|
(987,886
|
)
|
||||
|
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Acquisition of leasehold improvement with due to related party
|
29,064
|
- | ||||||
Acquisition of leasehold improvement
|
(29,064
|
) | - | |||||
Acquisition of property and equipment
|
(11,284
|
)
|
(35,414
|
)
|
||||
Net cash used by investing activities
|
(11,284
|
)
|
(35,414
|
)
|
||||
|
||||||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Proceeds from sale of common stock
|
-
|
65,000
|
||||||
Proceeds from convertible note payable
|
79,050
|
-
|
||||||
Payment on convertible note payable
|
(100,000
|
)
|
-
|
|||||
Common stock issued from exercise of options
|
-
|
150
|
||||||
Payment on due to related parties
|
(30,500
|
)
|
-
|
|||||
Proceeds from advances from related party
|
130,050
|
600,000
|
||||||
Proceeds from note payable to related party
|
405,000
|
-
|
||||||
Proceeds from reverse acquisition
|
-
|
180,854
|
||||||
Net cash provided by financing activities
|
483,600
|
846,004
|
||||||
|
||||||||
Net change in cash and cash equivalents
|
(15,461
|
)
|
(177,296
|
)
|
||||
|
||||||||
Cash and cash equivalents, beginning of the year
|
43,878
|
221,174
|
||||||
|
||||||||
Cash and cash equivalents, end of the year
|
$
|
28,417
|
$
|
43,878
|
||||
|
||||||||
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||
Cash paid for interest
|
$
|
5,000
|
$
|
48
|
||||
Cash paid for income taxes
|
$
|
-
|
$
|
-
|
||||
|
||||||||
NON-CASH FINANCING AND INVESTING ACTIVITIES:
|
||||||||
Common stock issued to acquire property
|
$
|
50,723
|
$
|
-
|
||||
Common stock issued from conversion of payable to related party
|
$
|
-
|
$
|
600,000
|
||||
Consolidation of related party note payable
|
$
|
153,400
|
$
|
-
|
||||
Common stock issued in reverse acquisition and recapitalization
|
$
|
-
|
$
|
48,830
|
||||
Changes in operating assets and liabilities due to reverse acquisition:
|
||||||||
Prepaid expenses
|
$
|
-
|
$
|
(3,434
|
)
|
|||
Property and equipment
|
$
|
-
|
$
|
(95,860
|
)
|
|||
Accumulated depreciation
|
$
|
-
|
$
|
44,332
|
||||
Deposits
|
$
|
-
|
$
|
(841
|
)
|
|||
Accounts payable
|
$
|
-
|
$
|
6,973
|
|
Level 1 – Quoted prices for identical instruments in active markets;
|
|
Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
|
|
Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
Quoted Active Markets for Identified Assets
|
Significant Other
Observable Inputs
|
Significant
Unobservable Inputs
|
Total
|
||||||||||||
|
||||||||||||||||
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
|||||||||||||
December 31, 2017
|
||||||||||||||||
Common stock issued for services
|
-
|
$
|
565,569
|
-
|
$
|
565,569
|
||||||||||
Stock for Interest
|
-
|
366,400
|
-
|
366,400
|
||||||||||||
Employee Stock Plan
|
-
|
75,415
|
-
|
75,415
|
||||||||||||
Stock for property acquisition
|
-
|
50,723
|
-
|
50,723
|
||||||||||||
|
||||||||||||||||
December 31, 2016
|
||||||||||||||||
Common stock issued for services
|
-
|
$
|
286,575
|
-
|
$
|
286,575
|
||||||||||
Common stock for related party payable
|
-
|
600,000
|
-
|
600,000
|
Note Date
|
Note Amount
|
Accrued Interest
|
Total
|
|||||||||
January 2017
|
$
|
300,000
|
$
|
16,504
|
$
|
316,504
|
||||||
June 2017
|
105,000
|
2,048
|
107,048
|
|||||||||
June 2017
|
130,050
|
2,564
|
132,614
|
|||||||||
535,050
|
21,116
|
556,166
|
||||||||||
Expenses owed to related party
|
2,234
|
|||||||||||
Principle of note payable to related party after consolidation
|
$
|
558,400
|
2017
|
2016
|
|||||||
Short term loan from related entity (1)
|
$
|
41,994
|
$
|
-
|
||||
Storage and corporate housing and auto allowances owed to CEO (2)
|
10,000
|
4,000
|
||||||
Amount owed to a director (3)
|
29,064
|
-
|
||||||
$
|
81,058
|
$
|
4,000
|
Land purchase price
|
$
|
26,194
|
||
Land preparation and cleanup
|
15,000
|
|||
Industrial Hemp Grower License
|
-
|
|||
Compensation
|
86,806
|
|||
Total Purchase Price
|
$
|
128,000
|
|
2017
|
2016
|
||||||
Raw materials
|
$
|
46,880
|
$
|
52,363
|
||||
Finished goods (isolates, tinctures and capsules, etc.)
|
10,377
|
10,722
|
||||||
|
$
|
57,257
|
$
|
63,085
|
2017
|
2016
|
|||||||
Computer equipment
|
$
|
7,582
|
$
|
26,672
|
||||
Website
|
5,000
|
5,000
|
||||||
Extraction and lab equipment
|
559,257
|
558,061
|
||||||
Land
|
50,723
|
-
|
||||||
Leasehold improvement
|
34,152
|
-
|
||||||
Total property and equipment
|
656,714
|
589,733
|
||||||
Less accumulated depreciation
|
(172,783
|
)
|
(108,886
|
)
|
||||
Net property and equipment
|
$
|
483,931
|
$
|
480,847
|
2017
|
2016
|
|||||||
Accounts payable to vendors
|
$
|
95,444
|
$
|
69,938
|
||||
Payroll taxes payable
|
24,727
|
11,092
|
||||||
Accrued salaries and bonuses
|
320,667
|
59,500
|
||||||
Accrued interest on note payable to related party
|
11,872
|
-
|
||||||
Accrued severance compensation to former CEO
|
-
|
250,000
|
||||||
$
|
452,710
|
$
|
390,530
|
1) |
10,000 shares to each director for services rendered for fiscal year 2016 and 10,000 shares for services to be rendered for fiscal year 2017, total 60,000 shares, valued at $99,000;
|
2) |
17,646 shares to a consultant for investors relations services, valued at $30,000;
|
3) |
50,000 shares to the Company’s SEC legal counsel for services performed, valued at $82,500;
|
4) |
10,000 shares to an employee for services performed, valued at $12,800;
|
5) |
110,000 shares to an investor and its affiliate as offering costs, valued at $184,800;
|
6) |
50,000 shares to a director for consulting services rendered in the convertible note and equity purchase agreement transactions, valued at $82,500;
|
7) |
100,000 shares issued as debt issuance cost to CEO for related party advances, valued at $182,000;
|
8) |
100,000 shares issued as interest expense to CEO for related party advances, valued at $158,000;
|
9) |
15,000 shares to a consultant for continuing services, valued at $23,400; and
|
10) |
80,000 shares to a director as other considerations and to purchase and prepare assets acquired by the Company’s subsidiary, valued at $128,000.
|
11) |
15,520 shares to a director for expenses incurred related to land excavation and clean up, valued at $9,529.
|
1)
|
6,466 shares were issued to a consultant to provide institutional funding services valued at $14,955. No additional service was performed after this issuance;
|
2)
|
15,846 shares were issued for advisory services performed in December 2016, valued at $30,000. The agreement provides for issuance of additional shares, priced at the 3-day closing average of the Company’s common stock, each month thereafter, for services performed through May 5, 2017;
|
3)
|
2,474,850 shares were issued to the MariJ shareholders in the acquisition transaction of January 15, 2016;
|
4)
|
130,000 shares were issued to directors as subscriptions for new purchased shares for $65,000 at $0.50 per share;
|
5)
|
15,000 shares were issued from exercise of common stock purchase options at $0.01 per share; and
|
6)
|
1,200,000 shares were issued to a related party to settle $600,000 of working capital advances at $0.50 per share;
|
7)
|
132,248 shares were issued to the former CEO valued at $238,000 pursuant to his anti-dilution agreement; and
|
8)
|
2,000 shares were issued for services performed by an independent consultant valued at $3,620.
|
Number of Shares
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Life (Yrs)
|
Aggregate Intrinsic Value
|
|||||||||||||
Outstanding at December 31, 2015
|
90,000
|
$
|
0.34
|
3.10
|
$
|
10,350
|
||||||||||
Granted
|
-
|
|||||||||||||||
Exercised
|
(15,000
|
)
|
$
|
0.01
|
||||||||||||
Forfeited or cancelled
|
-
|
|||||||||||||||
Outstanding at December 31, 2016
|
75,000
|
$
|
0.41
|
2.71
|
$
|
82,000
|
||||||||||
Granted
|
-
|
|||||||||||||||
Exercised
|
-
|
|||||||||||||||
Forfeited or cancelled
|
(10,000
|
)
|
$
|
0.80
|
||||||||||||
Outstanding at December 31, 2017
|
65,000
|
$
|
0.35
|
2.00
|
$
|
16,050
|
||||||||||
Exercisable at December 31, 2017
|
65,000
|
$
|
0.35
|
2.00
|
$
|
16,050
|
|
2016
|
|||||||
|
Number of Shares
|
Weighted Average
Exercise Price
|
||||||
Outstanding at December 31, 2015
|
1,000,000
|
$
|
3.00
|
|||||
Granted
|
-
|
-
|
||||||
Exercised
|
-
|
-
|
||||||
Forfeited or cancelled
|
-
|
-
|
||||||
Expired
|
1,000,000
|
$
|
3.00
|
|||||
Outstanding at December 31, 2016
|
-
|
$
|
-
|
|||||
Exercisable at December 31, 2016
|
-
|
$
|
-
|
|
2017
|
2016
|
||||||
Net (Loss)
|
$
|
(1,833,728
|
)
|
$
|
(1,785,114
|
)
|
||
Benefit (expense) for income taxes computed using the statutory rate of 21% and 34%, respectively
|
385,083
|
606,939
|
||||||
Non-deductible expense
|
(212,526
|
)
|
(99,086
|
)
|
||||
Remeasurement of deferred income taxes due to tax reform
|
(1,425,999
|
)
|
-
|
|||||
Change in valuation allowance
|
1,253,442
|
(507,853
|
)
|
|||||
Provision for income taxes
|
$
|
-
|
$
|
-
|
|
2017
|
2016
|
||||||
Total deferred tax assets – net operating losses
|
$
|
2,476,950
|
$
|
3,731,181
|
||||
Deferred tax liabilities
|
||||||||
Depreciation
|
- |
(789
|
)
|
|||||
Net deferred tax assets
|
2,476,950
|
3,730,392
|
||||||
Valuation allowance
|
(2,476,950
|
)
|
(3,730,392
|
)
|
||||
|
$
|
-
|
$
|
-
|
Expiring December 31,
|
Amount of NOL Expiring
|
|||
2019
|
$
|
6,166,000
|
||
2026
|
408,000
|
|||
2027
|
693,000
|
|||
2028
|
771,000
|
|||
2029
|
197,000
|
|||
2030
|
32,000
|
|||
2031
|
415,000
|
|||
2033
|
692,000
|
|||
2034
|
106,000
|
|||
2036
|
1,493,000
|
|||
2037
|
822,000
|
|||
|
$
|
11,795,000
|
Change in valuation allowance
|
||||
2017
|
$
|
(2,476,950
|
)
|
|
2016
|
(3,730,392
|
)
|
||
|
$
|
1,253,442
|
Years ending December, 31
|
||||||||||||
2018
|
2019
|
Total
|
||||||||||
Tennessee retail space lease
|
$
|
30,050
|
$
|
30,600
|
$
|
60,650
|
||||||
CEO housing allowance
|
12,000
|
12,000
|
24,000
|
|||||||||
CEO automobile allowance
|
12,000
|
12,000
|
24,000
|
|||||||||
$
|
54,050
|
$
|
54,600
|
$
|
108,650
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and
|
d) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Document And Entity Information - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2017 |
Mar. 27, 2018 |
Jun. 30, 2017 |
|
Document and Entity Information [Abstract] | |||
Entity Registrant Name | Acacia Diversified Holdings, Inc. | ||
Document Type | 10-K | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Common Stock, Shares Outstanding | 18,083,000 | ||
Entity Public Float | $ 20,153,131 | ||
Amendment Flag | false | ||
Entity Central Index Key | 0001001463 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Dec. 31, 2017 | ||
Document Fiscal Year Focus | 2017 | ||
Document Fiscal Period Focus | FY |
CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Accounts receivable, allowance for doubtful accounts (in Dollars) | $ 17,450 | $ 0 |
Accumulated depreciation (in Dollars) | $ 172,783 | $ 108,886 |
Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 150,000,000 | 150,000,000 |
Common stock, shares issued | 17,539,982 | 16,931,816 |
Common stock, shares outstanding | 17,539,982 | 16,931,816 |
NOTE 1 - THE COMPANY |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Disclosure Text Block [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | NOTE 1 - THE COMPANY Acacia Diversified Holdings, Inc. (“Acacia” or the “Company”) has three wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc. (“MariJ Pharma”), Canna-Cures Research & Development Center, Inc. (“Canna-Cures”), and Eufloria Medical of Tennessee, Inc. (“EMT”), a company incorporated in the state of Tennessee. The Company formed this new subsidiary to acquire a parcel of land and a license from one of its directors. See details in NOTE 5 - Related Party Transactions. Prior to the Merger (see NOTE 2), the Company sold the assets and related businesses of its Citrus Extracts, Inc. and Acacia Transport Services, Inc. subsidiaries, and its Acacia Milling Services operations, being all of its then revenue-producing operations, on June 29, 2015. On January 15, 2016 the Company entered into a definitive Asset Purchase Agreement to acquire substantially all of the assets of the “MariJ Group” of companies, including (1) MariJ Agricultural, Inc.; (2) Canna-Cures Research & Development Center, LLC; and, (3) JR Cannabis Industries, LLC with an effective date of January 4, 2016. In connection with the acquisition, the Company issued 2,474,850 shares of its common stock to the shareholders and members of the MariJ Group. In 2016, following those acquisitions, the Company formed two new subsidiaries to conduct its new medical cannabis business activities, being MariJ Pharmaceuticals, Inc. (“MariJ Pharma”) and Canna-Cures Research & Development Center, Inc. (“Canna-Cures”). In 2017, the Company formed a new subsidiary, Eufloria Medical of Tennessee, Inc. (“EMT”), a corporation formed under the laws of Tennessee. The Company’s primary source revenue is from the extraction of medicinal cannabis oil, from a non-psychoactive cannabis plant. All extraction services are currently limited to the State of Colorado, as the Company is attempting to attain various licenses for business in other states. |
NOTE 2 - REVERSE MERGER ACCOUNTING |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Business Combinations [Abstract] | |
Business Combination Disclosure [Text Block] | NOTE 2 - REVERSE MERGER ACCOUNTING On January 15, 2016 the Company entered into a definitive Asset Purchase Agreement to acquire substantially all of the assets of the “MariJ Group” of companies, including (1) MariJ Agricultural, Inc.; (2) Canna-Cures Research & Development Center, LLC; and, (3) JR Cannabis Industries, LLC with an effective date of January 4, 2016. In connection with the acquisition, the Company issued 2,474,850 shares of its common stock to the shareholders and members of the MariJ Group. As result of this transaction Rick Pertile, CEO of MariJ Group, became CEO and Chairman of the Board of Directors of Acacia. In addition two members of the Board of Directors of Acacia resigned and Mr. Pertile, together with the two remaining directors, appointed to Acacia’s Board two individuals that were owners and directors of the MariJ Group. After the acquisition, all company operations were those of the MariJ Group. The merger of the MariJ Group into the non-operating public company (Acacia), which had only nominal assets (total net assets aggregated $229,684, including cash of $180,854), is considered to be a capital transaction. The transaction was equivalent to the issuance of stock by the MariJ Group for the net assets of Acacia, accompanied by a recapitalization. The historical consolidated financial statements of the MariJ Group become the consolidated financial statements of the public company subsequent to the merger. The audited consolidated financial statements of the MariJ Group were included in the Current Report on Form 8-K/A filed April 25, 2016 by Acacia. |
NOTE 3 - GOING CONCERN |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | NOTE 3 - GOING CONCERN The Company has not generated profit to date. The Company expects to continue to incur operating losses as it proceeds with its extraction and research and development activities and continues to navigate it through the regulatory process. The Company expects general and administrative costs to increase, as the Company adds personnel and other administrative expenses associated with its current efforts. As such, and without substantially increasing revenue or finding new sources of capital, the Company will find it difficult to continue to meet its obligations as they come due. The Company is still locating new clients for its services and products, and the business is generally seasonal with the second and third quarters of the calendar year being the slowest as a result of it being the “off season” for outside grow of Cannabis hemp plants. There can be no assurance that the Company will be successful in its efforts to raise capital, or if it were successful in raising capital, that it would be successful in meeting its business plans. While the services performed by the Company’s MariJ Pharma subsidiary and sales of current inventory supplies, if sold on a seasonally-adjusted basis, are anticipated to be sufficient to meet the Company’s liquidity needs, these factors raise some doubt as to the ability of the Company to continue as a going concern. Management’s plans include increasing production at the Company’s new MariJ Pharma subsidiary during 2018, selling its inventories of products, attempting to start new businesses or find additional operational businesses to buy, and attempting to raise funds from the public through an equity offering of the Company’s common stock and from issuance of notes payable to related party. Management intends to make every effort to identify and develop all these sources of funds, but there can be no assurance that Management’s plans will be successful. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses for all periods presented and has a substantial accumulated deficit. As of December 31, 2017, these factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. |
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies [Text Block] | NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION - The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) with December 31, as its year-end. The consolidated financial statements and notes are the representations of the Company’s management who are responsible for their integrity and objectivity. PRINCIPLES OF CONSOLIDATION – The consolidated financial statements include the accounts of Acacia Diversified Holdings, Inc. and its wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc, Canna-Cures Research & Development Center, Inc and Eufloria Medical of Tennessee, Inc. All significant intercompany accounts and transactions are eliminated in consolidation. USE OF ESTIMATES - Preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions about current, and for some estimates, future economic and market conditions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. CASH AND CASH EQUIVALENTS - The Company considers all short-term investments purchased with a maturity of three months or less to be cash equivalents. Credit risk associated with cash deposits are insured under FDIC up to $250,000 per depositor, per FDIC insured bank, per ownership category. At such time, as the Company’s cash deposits exceed FDIC limits, the Company will reassess their credit risk. ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS – The Company’s accounts receivable represents amounts due from customers for extraction services performed. Allowance for uncollectible accounts receivable is estimated based on the aging of the accounts receivable and management estimate of uncollectible amounts. At December 31, 2017 and 2016, the Company provided for $17,450 and $0, respectively, of allowance for doubtful accounts. CONCENTRATION OF CUSTOMERS – For the year ended December 31, 2017, the Company’s extraction revenue, which accounted for 94% of total revenue, came from the Company’s three customers. These three customers accounted for approximately 33%, 28% and 32%, respectively, of total revenue. The entire trade receivable balance at December 31, 2017 was due from one customer. For the year ended December 31, 2016, all of the Company’s extraction revenue, which accounted for 95% of total revenue, came from the Company’s only two customers. One customer accounted for 72% while another customer accounted for 23% of the total revenue. The entire trade receivable balance at December 31, 2016 was due from one customer. INVENTORIES – Inventories are stated at the lower of cost or market. Cost is determined using the average cost method. The Company’s inventory consists of raw materials and finished goods. Cost of inventory includes cost of ingredients, labor, quality control and all other costs incurred to bring our inventories to condition ready to be sold. PROPERTY AND EQUIPMENT – Property and equipment are stated at cost less accumulated depreciation. Major renewals and improvements are capitalized, while minor replacements, maintenance and repairs are charged to current operations. Depreciation is computed by applying the straight-line method over the estimated useful lives, which are generally three to fifteen years. IMPAIRMENT OF LONG-LIVED ASSETS – In accordance with Accounting Standards Codification 360-10-05 - Impairment or Disposal of Long-Lived Assets, long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment at least annually or whenever facts and circumstances indicate that the carrying value may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. The Company did not recognize any impairment losses for the periods presented. DEBT ISSUANCE COSTS - The Company follows Accounting Standard Update 2015-03 – Simplifying the Presentation of Debt Issuance Costs, which requires direct costs associated with the issuance of convertible note to be presented in the balance sheet as a direct reduction from the carrying value of the associated debt liability. These costs are amortized into interest expense over the contractual term of the note or a shorter amortization period when deemed appropriate. The Company amortizes debt issuance costs for its convertible note immediately upon issuance since the note is convertible on demand. OFFERING COSTS - The Company follows the SEC Staff Accounting Bulletin, Topic 5 - Miscellaneous Accounting, which requires that specific incremental costs directly attributable to a proposed or actual offering of securities may be deferred and charged against gross receipts of the offering. However, deferred costs of an aborted offering, or a postponement of existing offering exceeding 90 days, may not be deferred and charged against proceeds of a subsequent offering. REVENUE RECOGNITION – The Company generates revenue from extracting and processing very high quality, high-cannabinoid profile content medical grade cannabis oils from medicinal cannabis plants. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: o persuasive evidence of an arrangement exists o the product has been shipped or the services have been rendered to the customer o the sales price is fixed or determinable o collectability is reasonably assured. ADVERTISING COSTS - Advertising costs are expensed as incurred. Advertising expense for the years ended December 31, 2017 and 2016 amounted to $8,516 and $15,427, respectively. FAIR VALUE OF FINANCIAL INSTRUMENTS - The carrying amounts of cash and cash equivalents, accounts receivable, deposits, prepaid expenses, accounts payable and accrued expenses approximate fair value due to the short-term nature of these instruments. Accounts payable and accrued expenses as of December 31, 2017 and 2016 included amounts due to vendors and service providers in the amounts of $452,710 and $390,530, respectively. Amount at December 31, 2017 also included accrued compensation to the Company’s officers. Amount at December 31, 2016 also included accrued compensation to the Company’s current CEO and severance compensation to the Company’s former CEO. FAIR VALUE ESTIMATES – The Company measures its options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:
This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value. No new options or warrants were issued during the years ended December 31, 2017 and 2016.
All common stock issued for services are valued on the date of the agreements, using quoted prices from over-the-counter markets. COMPENSATED ABSENCES - The Company has not accrued a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General, as the amount of the liability cannot be reasonably estimated at December 31, 2017 and 2016. LOSS PER COMMON SHARE - Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share would include the weighted average common shares outstanding and potentially dilutive common share equivalents. Because of the net losses for all periods presented, the basic and diluted weighted average shares outstanding are the same since including the additional shares would have an anti-dilutive effect on the loss per share. For this reason, common stock options and warrants to purchase 65,000 and 0 shares, respectively, of common stock were not included in the computation of basic and diluted weighted average common shares outstanding for the years ended December 31, 2017 and 2016. INCOME TAXES - The Company files federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state and local income taxes currently payable, as well as deferred taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company currently has substantial net operating loss carryforwards. The Company has recorded a valuation allowance equal to the net deferred tax assets due to the uncertainty of the ultimate realization of the deferred tax assets. CONTINGENCIES - Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is possible that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed. There was no known contingency at December 31, 2017. In the normal course of business, the Company also enters into various other guarantees and indemnities in its relationships with suppliers, service providers, customers and others. These guarantees and indemnifications do not materially impact the Company’s financial condition or results of operations, and indemnifications associated with the Company’s actions generally have no dollar limitations and currently cannot be quantified. STOCK BASED COMPENSATION - The Company accounts for stock-based compensation under Accounting Standards Codification 718 - Compensation-Stock Compensation (“ASC 718”). ASC 718 requires that all stock-based compensation be recognized as expense in the financial statements and that such cost be measured at the fair value of the award at the grant date and recognized over the period during which an employee is required to provide services (requisite service period). An additional requirement of ASC 718 is that estimated forfeitures be considered in determining compensation expense. Estimating forfeitures did not have a material impact on the determination of compensation expense during the years ended December 31, 2017 and 2016. The Company accounts for stock based awards based on the fair market value of the instrument using a 10-day volume weighted adjusted price (VWAP) and accounts for stock options issued using the Black-Scholes option pricing model and utilizing certain assumptions including the followings: Risk-free interest rate – This is the yield on U.S. Treasury Securities posted at the date of grant (or date of modification) having a term equal to the expected life of the option. An increase in the risk-free interest rate will increase compensation expense. Expected life—years – This is the period of time over which the options granted are expected to remain outstanding. Options granted by the Company had a maximum term of ten years. An increase in the expected life will increase compensation expense. Expected volatility – Actual changes in the market value of stock are used to calculate the volatility assumption. An increase in the expected volatility will increase compensation expense. Dividend yield – This is the annual rate of dividends per share over the exercise price of the option. An increase in the dividend yield will decrease compensation expense. The Company does not currently pay dividends and has no immediate plans to do so in the near future. The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of Accounting Standards Codification 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty’s performance is complete. |
NOTE 5 - RELATED PARTY TRANSACTIONS |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions Disclosure [Text Block] | NOTE 5 - RELATED PARTY TRANSACTIONS Note Payable to Related Party The following notes and advances, together with accrued interest, were consolidated into one single note payable to the Company’s CEO: (1) In January 2017, the Company entered into a note agreement in the amount of $300,000 with the Company’s CEO. The note bears interest at a rate of 8% per annum and specifies no due date. The Company accrued interest of $16,504 through September 25, 2017. Concurrently, the board of directors also approved issuance of 100,000 shares of the Company’s common stock as additional interest. These shares were accounted for as debt issuance costs, valued at $182,000. The costs were expensed at the commitment date of the note as interest expense since the note is a short term capital advance with no stated term. This note was convertible into the shares of the Company’s common stock at $0.50/share and the note holder did not exercise the conversion option. (2) In June 2017, the Company entered into a note agreement in the amount of $105,000 with the Company’s CEO for short term working capital advance. The note bears interest at a rate of 8% per annum and specifies no due date. The Company accrued interest and recorded interest expense of $2,048 through September 25, 2017. This note was convertible into the shares of the Company’s common stock at $0.50/share and the note holder did not exercise the conversion option. (3) In June 2017, the Company received a short term working capital advance of $130,050 from its CEO. The advance bears interest at a rate of 8% per annum and specifies no due date. The Company accrued interest and recorded interest expense of $2,564 through September 25, 2017. (4) On September 25, 2017, the board of directors approved the Company to enter into a consolidated note payable agreement with the Company’s CEO to consolidate notes and advances received from its CEO, including accrued interests on these notes.
The consolidated note payable bears interest at 8% and is due and payable on demand or first from any capital raised. The note is secured by a first lien on the assets of the Company and its subsidiaries. The Company accrued interest and recorded interest expense of $11,872 for the period September 25, 2017 to December 31, 2017 and is included in accrued liabilities. Payable to Related Parties Payable to related parties consisted of the followings at December 31, 2017 and 2016:
(1) In 2017, the Company received a working capital advance of $74,348 from a related entity. These advances are non-interest bearing and were intended as short term capital advances. The remaining balances of $41,994 have been included in payable to related parties on the consolidated balance sheet as current liabilities at December 31, 2017. (2) On May 1, 2016, the Company entered into an employment agreement with its CEO. The term of the employment is through December 31, 2019. The agreement provides for a monthly storage and corporate housing allowance of $1,000 for a property owned by the CEO and a monthly automobile allowance of $1,000. During the year ended December 31, 2017, expenses related to the housing and automobile allowances totaled $24,000, of which $10,000 remained owed to the Company’s CEO at December 31, 2017. During the year ended December 31, 2016, expenses related to the housing and automobile allowances totaled $16,000, of which $4,000 remained owed to the CEO at December 31, 2016. (3) During the year ended December 31, 2017, a director of the Company incurred time and expenses related to improving the retail space located in Tennessee. These costs have been recorded as property and equipment in the Company’s consolidated balance sheet at December 31, 2017. At December 31, 2017, the Company owed this director $29,064, of which $17,648 was paid after December 31, 2017 through issuance of 36,018 shares of the Company’s common stock to the director. Other Related Party Transactions In March 2017, the Company’s board of directors approved issuance of 50,000 shares of the Company’s common stock to a director for his service in a financing transaction and the equity purchase agreement described in NOTES 9 and 10. The Company determined that 16,000 shares of the total number of shares represent non-cash debt issuance costs directly related to the convertible notes financing and the remaining 34,000 shares represent compensation costs directly related to the equity purchase agreement with this investor. These shares were valued at $82,500. In May 2017, the Company and EMT entered into an agreement to purchase a parcel of land in Tennessee and an Industrial Hemp Grower License issued by the Tennessee Department of Agriculture from one of the Company’s directors. The purchase price of the transaction was 80,000 shares of the Company’s restricted common stock. These shares were valued at $1.60 per share, or $128,000, on the commitment date. EMT allocated the purchase price among the assets acquired based on their fair values as follow:
The Company determined the value of the land based on the purchase price paid by the director in December 2016. There has been no significant changes in the value of the land since that time. The Company estimated land preparation and cleanup costs at $15,000. The director applied for and paid a fee of $264 to obtain the license. The Company was not able to determine the value of the license since the license was granted as part of the hemp pilot program in Tennessee and the Company has not generated any cash flows from this license. The Company entered into this agreement with its director, in lieu of the state of Tennessee, as a result of the state’s residency requirement to enter into the program in Tennessee. As a result, this director is also a registered agent and a director of EMT, a Tennessee corporation. The remaining purchase price of $86,806 represented compensation to this director for his effort in preparing the Company for operations in Tennessee. During the year ended December 31, 2017, this director also incurred expenses in excavating and clearing of the land, installing driveway and culvert and completing the survey for excavation. The board of directors approved issuance of the Company’s common stock to compensate this director for his expenses. As a result, the Company recorded its commitment to issue 15,520 shares of its common stock valued at $0.61 per share, for a total of $9,529, which is included as part of the cost of the land. Accordingly, the total recorded cost of the Tennessee land acquisition is $50,723. During the year ended December 31, 2017, the Company issued 20,000 shares of the Company’s common stock to each of its three directors for serving on the Company’s board during 2017 and 2016. The total of 60,000 shares were valued at $99,000. There was no cash compensation paid to the directors for their service on the board. During the year ended December 31, 2016, the Company paid $1,000 cash compensation to each of its four non-employee directors, totaled $4,000. During the year ended December 31, 2016, the Company’s CEO advanced working capital to the Company in multiple tranches that totaled $600,000 to fund operating expenses. In December 2016, the Company issued to the CEO 1,200,000 shares of the Company’s common stock at $0.50 per share as payment in full of this advance. |
NOTE 6 - INVENTORIES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Text Block] | NOTE 6 - INVENTORIES The Company’s inventories consisted of the followings at December 31, 2017 and 2016:
|
NOTE 7 - PROPERTY AND EQUIPMENT |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment Disclosure [Text Block] | NOTE 7 - PROPERTY AND EQUIPMENT Property and equipment are stated at historical cost less accumulated depreciation. Depreciation is computed using the straight-line method at rates intended to depreciate the costs of assets over their estimated useful lives. Upon retirement or sale of property and equipment, the cost of the disposed assets and related accumulated depreciation is removed from the accounts and any resulting gain or loss is credited or charged to selling, general and administrative expenses. Expenditures for normal repairs and maintenance are charged to expense as incurred. Additions and expenditures for improving or rebuilding existing assets that extend the useful life are capitalized. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured. Property and equipment consisted of the followings at December 31, 2017 and 2016:
Depreciation expense for the years ended December 31, 2017 and 2016 totaled $78,457 and $76,860, respectively. |
NOTE 8 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | NOTE 8 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consisted of the followings at December 31, 2017 and 2016:
|
NOTE 9 - CONVERTIBLE NOTE PAYABLE |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | NOTE 9 - CONVERTIBLE NOTE PAYABLE In March 2017, the Company entered into a financing agreement with an investor whereby the Company would issue unsecured convertible note agreements to the investor in the aggregate principal amount of $400,000 at 10% discount. The financing would be funded in tranches, each with the issuance of a separate convertible note agreement by the Company. On March 31, 2017, the Company issued the first convertible note agreement (“first note”) in the principal amount of $100,000 at 10% discount. The first note matures on March 31, 2019 and is convertible into the Company’s common stock at a conversion price of $1.60 per share if no event of default has occurred and is converted prior to 180 days after the issuance date. If an event of default has occurred or the date of conversion is 180 days after the issuance date, the conversion price will be the lesser of $1.60 per share, or 70% of the second lowest closing bid price of the Company’s common stock for the 20 trading days immediately preceding the date of the conversion. In connection with the issuance of the first note, the Company paid $2,500 of commitment fee to the investor, $2,500 legal fees, and a finders fee of $5,950. Therefore, the Company received net proceeds of $79,050 at closing. The Company’s board of directors approved issuance of 50,000 shares of the Company’s common stock to a director for his service as a consultant for the transaction. The Company determined that 16,000 shares of the total number of shares represent non-cash debt issuance costs directly related to the convertible notes financing and the remaining 34,000 shares represent compensation costs directly related to the sale of the Company’s common stock to this investor (see NOTE 10). As a result, the debt discount of $10,000, commitment fee of $2,500, legal fee of $2,500, commission to a third party consultant of $5,950 and the non-cash debt issuance costs of $26,400, totaling $47,350, were recorded as a direct reduction from the carrying value of the principal amount in the consolidated balance sheet at the time of the agreement. These costs were amortized as interest expense immediately upon issuance because the first note was immediately convertible by the note holder. The principle amount of $100,000 was repaid in June 2017 together with interest expense of $5,000. The Company did not receive additional funding from the investor and therefore, no additional convertible note agreement was issued. |
NOTE 10 - STOCKHOLDERS' EQUITY |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note Disclosure [Text Block] | NOTE 10 - STOCKHOLDERS’ EQUITY Common Stock The Company has been authorized to issue 150,000,000 shares of common stock, $.001 par value. Each share of issued and outstanding common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution. During the year ended December 31, 2017, the Company issued 608,166 shares of its restricted common stock as follows:
During the year ended December 31, 2016 the Company issued 3,976,410 shares of its common stock as follows:
Warrants and Options At its meeting of directors on February 1, 2007, the Company’s board of directors approved the Acacia Automotive, Inc. 2007 Stock Incentive Plan1 (the “Plan”), which was approved by our stockholders on November 2, 2007, reserving 1,000,000 shares to be issued there under in the form of common stock or common stock purchase options. On July 26, 2012, our shareholders voted to update and extend the Acacia Automotive, Inc. 2007 Stock Incentive Plan, renaming it the Acacia Diversified Holdings, Inc. 2012 Stock Incentive Plan. Warrants, which may be included as equity compensation of used in other manners, are not a component of the Plan. On June 29, 2015 shareholders holding a majority of the shares of the Company voted to discontinue the Company’s stock incentive plans. At December 31, 2017, 65,000 options still remained outstanding. The Company did not issue any common stock purchase warrants or options during the years ended December 31, 2017 and 2016. The following tables represent stock options and warrants activities for the years ended December 31, 2017 and 2016. Stock Options
* Of the 65,000 options still active as of December 31, 2017: (i) 15,000 expire at 12-31-2018; (ii) 30,000 expire at 11-6-2019; and, (iii) 20,000 expire at 12-23-2020. Stock Warrants At December 31, 2017 and 2016, there were no outstanding and exercisable stock purchase warrants. The following summarizes the warrant activities during the year ended December 31, 2016:
Equity Purchase Agreement In March 2017, the Company entered into an equity purchase agreement (“agreement”) with an investor whereby the investor will purchase up to $5,000,000 of the Company’s common stock over a period of 24 months from the effective date of the Company’s Registration Statement. The investor will purchase the Company’s common stock at a 10% discount. Pursuant to the agreement, the Company issued to the investor, and its affiliate, 110,000 shares of its common stock as commitment fee. These shares are valued at $184,800 at the commitment date and are deemed direct incremental costs associated with the offering. Subsequent to filing the Registration Statement, the Company withdrew its filing, and therefore, these costs are expensed as general and administrative expense. The Company’s board of directors approved issuance of 50,000 shares of the Company’s common stock to a director for his service as a consultant of the transaction. The Company determined that 34,000 shares of the total number of shares approved for issuance represent compensation costs directly related the sale of the Company’s common stock to this investor. These shares are valued at $56,100 on commitment date are deemed direct incremental costs associated with the offering. Subsequent to filing the Registration Statement, the Company withdrew its filing, and therefore, these costs are expensed as general and administrative expense. Restricted Stock Awards to Key Employees In March 2017, the board of directors approved issuance of 100,000 shares of the Company’s restricted common stock to its key employees. The award for the employees are subject to a four or five-year vesting requirements, i.e. the requisite service period. The shares are issued as the vesting restriction lapses. The Company valued these shares at fair value on commitment date which is the date on which the employee accepted the award and recorded stock based compensation expense over the requisite service period. During the year ended December 31, 2017, the board of directors approved issuance of 10,000 shares of the Company’s common stock to one of the key employees as the vesting requirement was met. These shares were valued at $12,800 on commitment date. Stock based compensation expense for these awards for the year ended December 31, 2017 was $62,616. There was no restricted stock awarded to key employees in 2016. |
NOTE 11 - INCOME TAXES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Text Block] | NOTE 11 - INCOME TAXES As of December 31, 2017 and 2016 the Company had net operating loss carryforwards of approximately $11,795,000 and $10,973,000, respectively, which will expire beginning at the end of 2019. A valuation allowance has been provided for the deferred tax asset as it is uncertain whether the Company will have future taxable income. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act reduces the corporate tax rate to 21%, effective January 1, 2018. Consequently, we have recorded $1,425,999 adjustment to the deferred tax provision for the year ended December 31, 2017. A reconciliation of the benefit (expense) for income taxes with amounts determined by applying the statutory federal income rate of 21% in 2017 and 34% in 2016 to the respective losses before income taxes is as follows:
Significant components of the Company's deferred tax liabilities and assets at December 31, 2017 and 2016 are as follows:
As of December 31, 2017, open Federal income tax years subject to examination include the tax years ended December 31, 2016 through 2014. At December 31, 2017, net operating loss (“NOL”) carryforwards expiring through 2037 were as follows:
The net change in the valuation allowance is as follow:
The accounting for the effects of the rate change on deferred tax balances is complete and no provisional amounts were recorded for this item. |
NOTE 12 - LEASES AND COMMITMENTS |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Text Block] | NOTE 12 - LEASES AND COMMITMENTS The Company rents administrative space in Clearwater, Florida at $904 per month on a month to month basis, rents retail space in Pueblo, Colorado at $2,000 per month on a month to month basis until July 2017 and rents retail space in Nashville, Tennessee at $2,500 per month beginning in December 2017 for the first twelve months and at $2,250 per month for the next twelve months. The Company also rented a small apartment at $750 per month until December 31, 2016. On May 1, 2016, the Company entered into an employment agreement with its CEO. The term of the employment is through December 31, 2019 and at a starting salary of $170,000 and annual bonus at 35% of the salary. The salary for our CEO for the year 2017 was $195,000. Any salary and bonus increases must be reviewed and approved by the Company’s board of directors. The agreement provides for a monthly storage and corporate housing allowance of $1,000 for the rental of a second office owned by the CEO and a monthly automobile allowance of $1,000. During the year ended December 31, 2017, expenses related to the housing and automobile allowances totaled $24,000, of which $10,000 remained owed to the Company’s CEO at December 31, 2017. During the year ended December 31, 2016, expenses related to the housing and automobile allowances totaled $16,000, of which $4,000 remained owed to the CEO at December 31, 2016. As such, the Company is committed to an annual expenditures of $24,000 for each of the years ended December 31, 2018 and 2019. The Company’s commitment to these expenditures are as follow:
Rent expense for the above leases and commitments for the years ended December 31, 2017 and 2016 were approximately $46,200 and $35,300, respectively. |
NOTE 13 - RECENT ACCOUNTING PRONOUNCEMENTS |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
New Accounting Pronouncements and Changes in Accounting Principles [Text Block] | NOTE 13 - RECENT ACCOUNTING PRONOUNCEMENTS In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which will replace numerous requirements in U.S. GAAP, including industry specific requirements, and provide companies with a single revenue recognition model for recognizing revenue from contracts with customers. The core principle of the new standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The two permitted transition methods under the new standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented and the cumulative effect of applying the standard would be recognized at the earliest period shown, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application. In July 2015, the FASB approved the deferral of the new standard’s effective date by one year. The new standard is effective for annual reporting periods beginning after December 15, 2017. The FASB will permit companies to adopt the new standard early, but not before the original effective date of annual reporting periods beginning after December 15, 2016, but the Company is not planning to early adopt the new standard. Subsequent to the issuance of this new standard, the FASB also issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing in April 2016 and ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow Scope Improvements and Practical Expedients in May 2016. The effective dates and transition requirements for these amendments in these updates are the same as those for Topic 606. The Company is currently evaluating the effect this standard will have on its consolidated financial statements and related disclosures and its method of adoption. In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330), which simplifies its current requirement that an entity measure inventory at lower of cost or market, when market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. Inventory within the scope of ASU 2015-11 should be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. ASU 2015-11 is effective for financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within fiscal years beginning after December 15, 2017. The Company is evaluating the effect that ASU 2015-11 will have on its consolidated financial statements and related disclosures. In February 2016, the FASB issued ASU 2016-02, Leases, which aims to make leasing activities more transparent and comparable and requires substantially all leases be recognized by lessees on their balance sheet as a right-of-use asset and corresponding lease liability, including leases currently accounted for as operating leases. This ASU is effective for all interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its consolidated financial statements and related disclosures. |
NOTE 14 - SUBSEQUENT EVENTS |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | NOTE 14 - SUBSEQUENT EVENTS The Company evaluated subsequent events through April 2, 2018, the date the financial statements were issued, and determined that there were no other material events to disclose, other than the followings: In February 2018, the Company adopted the Acacia Diversified Holdings, Inc. 2018 Stock Grant and Option Plan (“2018 Plan”). The purpose of the 2018 Plan is to offer selected employees, directors and consultants an opportunity to acquire a proprietary interest in the success of the Company. Awards that can be granted from the 2018 Plan include registered shares, restricted shares and options as well as the direct award or sale of shares of the Company’s common stock. The aggregate number of shares which may be issued or transferred pursuant to an award shall not exceed 5,000,000 shares of authorized common stock of the Company. Subsequent to the adoption of the 2018 Plan, the Company filed Form S-8 with the Securities and Exchange Commission to register 1,000,000 shares of the Company’s common stock pursuant to a one-year consulting agreement beginning in February 2018. The board of directors also approved the Company issue 500,000 shares to the consultant to begin the agreement. During the year ended December 31, 2017, a director of the Company incurred time and expenses related to improving the retail space located in Tennessee. These costs have been recorded as property and equipment in the Company’s consolidated balance sheet at December 31, 2017. At December 31, 2017, the Company owed this director $29,064, of which $17,648 was paid on March 1, 2018 through issuance of 36,018 shares of the Company’s common stock to the director. On March 1, 2018, the Company also issued its SEC counsel 15,000 shares of the Company’s common stock for services to be performed in 2018. On March 1, 2018, the Company also issued an unrelated party 2,000 shares of the Company’s common stock pursuant to a licensing agreement the Company entered into with this party in August 2016. On March 19, 2018, the Company entered into a promissory note agreement with its CEO for a working capital advance of $12,000. The note bears interest at 8% per annum and is due in 60 days. On March 26, 2018, the Company entered into a promissory note agreement with its CEO for a working capital advance of $40,000. The note bears interest at 8% per annum and is due in 60 days. On March 30, 2018, the Company entered into a promissory note agreement with its CEO for a working capital advance of $20,000. The note bears interest at 8% per annum and is due in 60 days. |
Accounting Policies, by Policy (Policies) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Accounting, Policy [Policy Text Block] | BASIS OF PRESENTATION - The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) with December 31, as its year-end. The consolidated financial statements and notes are the representations of the Company’s management who are responsible for their integrity and objectivity. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidation, Policy [Policy Text Block] | PRINCIPLES OF CONSOLIDATION – The consolidated financial statements include the accounts of Acacia Diversified Holdings, Inc. and its wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc, Canna-Cures Research & Development Center, Inc and Eufloria Medical of Tennessee, Inc. All significant intercompany accounts and transactions are eliminated in consolidation. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Use of Estimates, Policy [Policy Text Block] | USE OF ESTIMATES - Preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions about current, and for some estimates, future economic and market conditions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents, Policy [Policy Text Block] | CASH AND CASH EQUIVALENTS - The Company considers all short-term investments purchased with a maturity of three months or less to be cash equivalents. Credit risk associated with cash deposits are insured under FDIC up to $250,000 per depositor, per FDIC insured bank, per ownership category. At such time, as the Company’s cash deposits exceed FDIC limits, the Company will reassess their credit risk. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables, Policy [Policy Text Block] | ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS – The Company’s accounts receivable represents amounts due from customers for extraction services performed. Allowance for uncollectible accounts receivable is estimated based on the aging of the accounts receivable and management estimate of uncollectible amounts. At December 31, 2017 and 2016, the Company provided for $17,450 and $0, respectively, of allowance for doubtful accounts. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Concentration Risk, Credit Risk, Policy [Policy Text Block] | CONCENTRATION OF CUSTOMERS – For the year ended December 31, 2017, the Company’s extraction revenue, which accounted for 94% of total revenue, came from the Company’s three customers. These three customers accounted for approximately 33%, 28% and 32%, respectively, of total revenue. The entire trade receivable balance at December 31, 2017 was due from one customer. For the year ended December 31, 2016, all of the Company’s extraction revenue, which accounted for 95% of total revenue, came from the Company’s only two customers. One customer accounted for 72% while another customer accounted for 23% of the total revenue. The entire trade receivable balance at December 31, 2016 was due from one customer. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory, Policy [Policy Text Block] | INVENTORIES – Inventories are stated at the lower of cost or market. Cost is determined using the average cost method. The Company’s inventory consists of raw materials and finished goods. Cost of inventory includes cost of ingredients, labor, quality control and all other costs incurred to bring our inventories to condition ready to be sold. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment, Policy [Policy Text Block] | PROPERTY AND EQUIPMENT – Property and equipment are stated at cost less accumulated depreciation. Major renewals and improvements are capitalized, while minor replacements, maintenance and repairs are charged to current operations. Depreciation is computed by applying the straight-line method over the estimated useful lives, which are generally three to fifteen years. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | IMPAIRMENT OF LONG-LIVED ASSETS – In accordance with Accounting Standards Codification 360-10-05 - Impairment or Disposal of Long-Lived Assets, long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment at least annually or whenever facts and circumstances indicate that the carrying value may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. The Company did not recognize any impairment losses for the periods presented. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt, Policy [Policy Text Block] | DEBT ISSUANCE COSTS - The Company follows Accounting Standard Update 2015-03 – Simplifying the Presentation of Debt Issuance Costs, which requires direct costs associated with the issuance of convertible note to be presented in the balance sheet as a direct reduction from the carrying value of the associated debt liability. These costs are amortized into interest expense over the contractual term of the note or a shorter amortization period when deemed appropriate. The Company amortizes debt issuance costs for its convertible note immediately upon issuance since the note is convertible on demand. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offering Costs, Policy [Policy Text Block] | OFFERING COSTS - The Company follows the SEC Staff Accounting Bulletin, Topic 5 - Miscellaneous Accounting, which requires that specific incremental costs directly attributable to a proposed or actual offering of securities may be deferred and charged against gross receipts of the offering. However, deferred costs of an aborted offering, or a postponement of existing offering exceeding 90 days, may not be deferred and charged against proceeds of a subsequent offering. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition, Policy [Policy Text Block] | REVENUE RECOGNITION – The Company generates revenue from extracting and processing very high quality, high-cannabinoid profile content medical grade cannabis oils from medicinal cannabis plants. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: o persuasive evidence of an arrangement exists o the product has been shipped or the services have been rendered to the customer o the sales price is fixed or determinable o collectability is reasonably assured. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Advertising Costs, Policy [Policy Text Block] | ADVERTISING COSTS - Advertising costs are expensed as incurred. Advertising expense for the years ended December 31, 2017 and 2016 amounted to $8,516 and $15,427, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments, Policy [Policy Text Block] | FAIR VALUE OF FINANCIAL INSTRUMENTS - The carrying amounts of cash and cash equivalents, accounts receivable, deposits, prepaid expenses, accounts payable and accrued expenses approximate fair value due to the short-term nature of these instruments. Accounts payable and accrued expenses as of December 31, 2017 and 2016 included amounts due to vendors and service providers in the amounts of $452,710 and $390,530, respectively. Amount at December 31, 2017 also included accrued compensation to the Company’s officers. Amount at December 31, 2016 also included accrued compensation to the Company’s current CEO and severance compensation to the Company’s former CEO. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurement, Policy [Policy Text Block] | FAIR VALUE ESTIMATES – The Company measures its options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:
This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value. No new options or warrants were issued during the years ended December 31, 2017 and 2016.
All common stock issued for services are valued on the date of the agreements, using quoted prices from over-the-counter markets. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensated Absences Policy [Policy Text Block] | COMPENSATED ABSENCES - The Company has not accrued a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General, as the amount of the liability cannot be reasonably estimated at December 31, 2017 and 2016. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share, Policy [Policy Text Block] | LOSS PER COMMON SHARE - Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share would include the weighted average common shares outstanding and potentially dilutive common share equivalents. Because of the net losses for all periods presented, the basic and diluted weighted average shares outstanding are the same since including the additional shares would have an anti-dilutive effect on the loss per share. For this reason, common stock options and warrants to purchase 65,000 and 0 shares, respectively, of common stock were not included in the computation of basic and diluted weighted average common shares outstanding for the years ended December 31, 2017 and 2016. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax, Policy [Policy Text Block] | INCOME TAXES - The Company files federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state and local income taxes currently payable, as well as deferred taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company currently has substantial net operating loss carryforwards. The Company has recorded a valuation allowance equal to the net deferred tax assets due to the uncertainty of the ultimate realization of the deferred tax assets. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies, Policy [Policy Text Block] | CONTINGENCIES - Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is possible that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed. There was no known contingency at December 31, 2017. In the normal course of business, the Company also enters into various other guarantees and indemnities in its relationships with suppliers, service providers, customers and others. These guarantees and indemnifications do not materially impact the Company’s financial condition or results of operations, and indemnifications associated with the Company’s actions generally have no dollar limitations and currently cannot be quantified. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | STOCK BASED COMPENSATION - The Company accounts for stock-based compensation under Accounting Standards Codification 718 - Compensation-Stock Compensation (“ASC 718”). ASC 718 requires that all stock-based compensation be recognized as expense in the financial statements and that such cost be measured at the fair value of the award at the grant date and recognized over the period during which an employee is required to provide services (requisite service period). An additional requirement of ASC 718 is that estimated forfeitures be considered in determining compensation expense. Estimating forfeitures did not have a material impact on the determination of compensation expense during the years ended December 31, 2017 and 2016. The Company accounts for stock based awards based on the fair market value of the instrument using a 10-day volume weighted adjusted price (VWAP) and accounts for stock options issued using the Black-Scholes option pricing model and utilizing certain assumptions including the followings: Risk-free interest rate – This is the yield on U.S. Treasury Securities posted at the date of grant (or date of modification) having a term equal to the expected life of the option. An increase in the risk-free interest rate will increase compensation expense. Expected life—years – This is the period of time over which the options granted are expected to remain outstanding. Options granted by the Company had a maximum term of ten years. An increase in the expected life will increase compensation expense. Expected volatility – Actual changes in the market value of stock are used to calculate the volatility assumption. An increase in the expected volatility will increase compensation expense. Dividend yield – This is the annual rate of dividends per share over the exercise price of the option. An increase in the dividend yield will decrease compensation expense. The Company does not currently pay dividends and has no immediate plans to do so in the near future. The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of Accounting Standards Codification 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty’s performance is complete. |
NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] |
This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value. No new options or warrants were issued during the years ended December 31, 2017 and 2016.
|
NOTE 5 - RELATED PARTY TRANSACTIONS (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt [Table Text Block] |
The following notes and advances, together with accrued interest, were consolidated into one single note payable to the Company’s CEO:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Related Party Transactions [Table Text Block] |
Payable to related parties consisted of the followings at December 31, 2017 and 2016:
(1) In 2017, the Company received a working capital advance of $74,348 from a related entity. These advances are non-interest bearing and were intended as short term capital advances. The remaining balances of $41,994 have been included in payable to related parties on the consolidated balance sheet as current liabilities at December 31, 2017. (2) On May 1, 2016, the Company entered into an employment agreement with its CEO. The term of the employment is through December 31, 2019. The agreement provides for a monthly storage and corporate housing allowance of $1,000 for a property owned by the CEO and a monthly automobile allowance of $1,000. During the year ended December 31, 2017, expenses related to the housing and automobile allowances totaled $24,000, of which $10,000 remained owed to the Company’s CEO at December 31, 2017. During the year ended December 31, 2016, expenses related to the housing and automobile allowances totaled $16,000, of which $4,000 remained owed to the CEO at December 31, 2016. (3) During the year ended December 31, 2017, a director of the Company incurred time and expenses related to improving the retail space located in Tennessee. These costs have been recorded as property and equipment in the Company’s consolidated balance sheet at December 31, 2017. At December 31, 2017, the Company owed this director $29,064, of which $17,648 was paid after December 31, 2017 through issuance of 36,018 shares of the Company’s common stock to the director. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Business Acquisitions, by Acquisition [Table Text Block] |
EMT allocated the purchase price among the assets acquired based on their fair values as follow:
|
NOTE 6 - INVENTORIES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||
Schedule of Inventory, Current [Table Text Block] |
The Company’s inventories consisted of the followings at December 31, 2017 and 2016:
|
NOTE 7 - PROPERTY AND EQUIPMENT (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Table Text Block] |
Property and equipment consisted of the followings at December 31, 2017 and 2016:
|
NOTE 8 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accrued Liabilities [Table Text Block] |
Accounts payable and accrued expenses consisted of the followings at December 31, 2017 and 2016:
|
NOTE 10 - STOCKHOLDERS' EQUITY (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation, Stock Options, Activity [Table Text Block] |
The Company did not issue any common stock purchase warrants or options during the years ended December 31, 2017 and 2016. The following tables represent stock options and warrants activities for the years ended December 31, 2017 and 2016.
* Of the 65,000 options still active as of December 31, 2017: (i) 15,000 expire at 12-31-2018; (ii) 30,000 expire at 11-6-2019; and, (iii) 20,000 expire at 12-23-2020. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] |
At December 31, 2017 and 2016, there were no outstanding and exercisable stock purchase warrants. The following summarizes the warrant activities during the year ended December 31, 2016:
|
NOTE 11 - INCOME TAXES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] |
A reconciliation of the benefit (expense) for income taxes with amounts determined by applying the statutory federal income rate of 21% in 2017 and 34% in 2016 to the respective losses before income taxes is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] |
Significant components of the Company's deferred tax liabilities and assets at December 31, 2017 and 2016 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Operating Loss Carryforwards [Table Text Block] |
As of December 31, 2017, open Federal income tax years subject to examination include the tax years ended December 31, 2016 through 2014. At December 31, 2017, net operating loss (“NOL”) carryforwards expiring through 2037 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Valuation Allowance [Table Text Block] |
The net change in the valuation allowance is as follow:
|
NOTE 12 - LEASES AND COMMITMENTS (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] |
The Company’s commitment to these expenditures are as follow:
|
NOTE 1 - THE COMPANY (Details) |
12 Months Ended | ||
---|---|---|---|
Jan. 04, 2016
shares
|
Dec. 31, 2017 |
Dec. 31, 2016 |
|
NOTE 1 - THE COMPANY (Details) [Line Items] | |||
Number of Wholly Owned Subsidiaries | 3 | 2 | |
MariJ Group [Member] | |||
NOTE 1 - THE COMPANY (Details) [Line Items] | |||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | 2,474,850 |
NOTE 2 - REVERSE MERGER ACCOUNTING (Details) - USD ($) |
Jan. 04, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|---|
NOTE 2 - REVERSE MERGER ACCOUNTING (Details) [Line Items] | |||
Assets | $ 606,800 | $ 684,783 | |
MariJ Group [Member] | |||
NOTE 2 - REVERSE MERGER ACCOUNTING (Details) [Line Items] | |||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | 2,474,850 | ||
Acacia [Member] | |||
NOTE 2 - REVERSE MERGER ACCOUNTING (Details) [Line Items] | |||
Assets | $ 229,684 | ||
Cash | $ 180,854 |
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt - USD ($) |
12 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2017 |
Jan. 31, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | $ 0 | $ 600,000 | ||
Total related party | 558,400 | $ 0 | ||
Chief Executive Officer [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | $ 316,504 | 556,166 | ||
Expenses owed to related party | 2,234 | |||
Total related party | 558,400 | |||
Chief Executive Officer [Member] | June 2017 #1 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | $ 107,048 | |||
Chief Executive Officer [Member] | June 2017 #2 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | 132,614 | |||
Principal [Member] | Chief Executive Officer [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | 300,000 | 535,050 | ||
Principal [Member] | Chief Executive Officer [Member] | June 2017 #1 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | 105,000 | |||
Principal [Member] | Chief Executive Officer [Member] | June 2017 #2 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | 130,050 | |||
Accrued Interest [Member] | Chief Executive Officer [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | $ 16,504 | $ 21,116 | ||
Accrued Interest [Member] | Chief Executive Officer [Member] | June 2017 #1 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | 2,048 | |||
Accrued Interest [Member] | Chief Executive Officer [Member] | June 2017 #2 [Member] | ||||
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Debt [Line Items] | ||||
Notes and accrued interest | $ 2,564 |
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Related Party Transactions - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
|||||||
---|---|---|---|---|---|---|---|---|---|
Related Party Transaction [Line Items] | |||||||||
Payable to Related Parties | $ 81,058 | $ 4,000 | |||||||
Affiliated Entity [Member] | Related Party Note #2 [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Payable to Related Parties | [1] | 41,994 | |||||||
Chief Executive Officer [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Payable to Related Parties | [2] | 10,000 | 4,000 | ||||||
Chief Executive Officer [Member] | Vehicles [Member] | |||||||||
Related Party Transaction [Line Items] | |||||||||
Payable to Related Parties | [3] | $ 29,064 | $ 0 | ||||||
|
NOTE 5 - RELATED PARTY TRANSACTIONS (Details) - Schedule of Business Acquisitions, by Acquisition - USD ($) |
1 Months Ended | |
---|---|---|
May 31, 2017 |
Mar. 31, 2017 |
|
Schedule of Business Acquisitions, by Acquisition [Abstract] | ||
Land purchase price | $ 26,194 | |
Land preparation and cleanup | 15,000 | $ 15,000 |
Industrial Hemp Grower License | 0 | |
Compensation | 86,806 | $ 86,806 |
Total Purchase Price | $ 128,000 |
NOTE 6 - INVENTORIES (Details) - Schedule of Inventory, Current - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Schedule of Inventory, Current [Abstract] | ||
Raw materials | $ 46,880 | $ 52,363 |
Finished goods (isolates, tinctures and capsules, etc.) | 10,377 | 10,722 |
$ 57,257 | $ 63,085 |
NOTE 7 - PROPERTY AND EQUIPMENT (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Property, Plant and Equipment [Abstract] | ||
Depreciation | $ 78,457 | $ 76,860 |
NOTE 7 - PROPERTY AND EQUIPMENT (Details) - Schedule of Property and Equipment - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | $ 656,714 | $ 589,733 |
Less accumulated depreciation | (172,783) | (108,886) |
Net property and equipment | 483,931 | 480,847 |
Computer Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | 7,582 | 26,672 |
Website Design [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | 5,000 | 5,000 |
Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | 559,257 | 558,061 |
Land [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | 50,723 | 0 |
Leasehold Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and Equipment | $ 34,152 | $ 0 |
NOTE 8 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - Schedule of Accrued Liabilities - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Schedule of Accrued Liabilities [Abstract] | ||
Accounts payable to vendors | $ 95,444 | $ 69,938 |
Payroll taxes payable | 24,727 | 11,092 |
Accrued salaries and bonuses | 320,667 | 59,500 |
Accrued interest on note payable to related party | 11,872 | 0 |
Accrued severance compensation to former CEO | 0 | 250,000 |
$ 452,710 | $ 390,530 |
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Mar. 31, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Face Amount | $ 105,000 | $ 100,000 | ||
Debt Discount Rate | 10.00% | |||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 0.50 | $ 1.60 | ||
Debt Instrument, Convertible, Terms of Conversion Feature | If an event of default has occurred or the date of conversion is 180 days after the issuance date, the conversion price will be the lesser of $1.60 per share, or 70% of the second lowest closing bid price of the Company’s common stock for the 20 trading days immediately preceding the date of the conversion. | |||
Proceeds from Convertible Debt | $ 79,050 | $ 79,050 | $ 0 | |
Stock Issued During Period, Shares, Other (in Shares) | 50,000 | |||
Stock Issued for Deferred Offering Cost, Shares (in Shares) | 16,000 | |||
Debt Instrument, Unamortized Discount | $ 10,000 | |||
Payments of Debt Issuance Costs | 26,400 | |||
Debt Instrument, Increase (Decrease), Other, Net | (47,350) | |||
Repayments of Convertible Debt | 100,000 | 0 | ||
Interest Paid | $ 5,000 | $ 48 | ||
Maximum [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Face Amount | 400,000 | |||
Commitment Fee [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Fee Amount | 2,500 | |||
Legal Fees [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Fee Amount | 2,500 | |||
Finder's Fee [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Fee Amount | $ 5,950 | |||
Non-Cash Offering Costs [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Stock Issued for Deferred Offering Cost, Shares (in Shares) | 34,000 | |||
Consultant Commissions [Member] | ||||
NOTE 9 - CONVERTIBLE NOTE PAYABLE (Details) [Line Items] | ||||
Debt Instrument, Fee Amount | $ 5,950 | |||
Repayments of Convertible Debt | $ 100,000 | |||
Interest Paid | $ 5,000 |
NOTE 10 - STOCKHOLDERS' EQUITY (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 25, 2017 |
Jan. 15, 2016 |
Mar. 31, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2014 |
Nov. 02, 2007 |
|
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Common Stock, Shares Authorized | 150,000,000 | 150,000,000 | |||||
Common Stock, Voting Rights | Each share of issued and outstanding common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution. | ||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 608,166 | 0 | |||||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 10,000 | ||||||
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars) | $ 12,800 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 565,569 | $ 286,575 | |||||
Stock Issued During Period, Shares, Other | 50,000 | ||||||
Stock Issued During Period, Value, Other (in Dollars) | $ 366,400 | ||||||
Stock Issued During Period, Value, Purchase of Assets (in Dollars) | $ 50,723 | ||||||
Shares, Issued | 3,976,410 | ||||||
Stock Issued During Period, Shares, Acquisitions | 2,474,850 | ||||||
Stock Issued During Period, Value, New Issues (in Dollars) | $ 65,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 0 | 15,000 | |||||
Common Stock, Capital Shares Reserved for Future Issuance | 1,000,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 65,000 | 75,000 | 90,000 | ||||
Stock Issued for Deferred Offering Cost, Shares | 16,000 | ||||||
Share-based Compensation (in Dollars) | $ 565,569 | $ 286,575 | |||||
Equity Purchase Agreement [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Value, Other (in Dollars) | $ 184,800 | ||||||
Equity Purchase Agreement, Maximum (in Dollars) | $ 5,000,000 | ||||||
Equity Purchase Agreement, Term | 24 years | ||||||
Common Stock Discount Rate | 10.00% | ||||||
Employee Stock Option [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.01 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 15,000 | ||||||
Restricted Stock [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Restricted Stock Award, Gross | 100,000 | ||||||
Share-based Compensation (in Dollars) | $ 62,616 | ||||||
Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 60,000 | ||||||
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars) | $ 99,000 | ||||||
Stock Issued During Period, Shares, Issued for Services | 50,000 | 60,000 | |||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 82,500 | $ 99,000 | |||||
Stock Issued During Period, Shares, Other | 15,520 | ||||||
Stock Issued During Period, Value, Other (in Dollars) | $ 9,529 | ||||||
Stock Issued During Period, Shares, Purchase of Assets | 80,000 | ||||||
Stock Issued During Period, Value, Purchase of Assets (in Dollars) | $ 128,000 | ||||||
Stock Issued During Period, Shares, New Issues | 130,000 | ||||||
Stock Issued During Period, Value, New Issues (in Dollars) | $ 65,000 | ||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.50 | ||||||
Stock Issued for Deferred Offering Cost, Shares | 56,100 | ||||||
Chief Executive Officer [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Other | 100,000 | ||||||
Stock Issued During Period, Value, Other (in Dollars) | $ 182,000 | ||||||
Stock Issued During Period, Shares Interest Expense | 100,000 | ||||||
Stock Issued During Period, Value, Interest Expense (in Dollars) | $ 158,000 | ||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.50 | ||||||
Related Party [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.50 | ||||||
Stock Issued During Period, Shares, Settle Debt | 1,200,000 | ||||||
Stock Issued During Period, Value, Settle Debt (in Dollars) | $ 600,000 | ||||||
Former Chief Executive Officer [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 132,248 | ||||||
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars) | $ 238,000 | ||||||
Stock Issued During Period, Shares, Other | 100,000 | ||||||
Services 2016 [Member] | Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 10,000 | ||||||
Services 2017 [Member] | Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 10,000 | ||||||
Commitment Fee [Member] | Equity Purchase Agreement [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Other | 110,000 | ||||||
Non-Cash Offering Costs [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued for Deferred Offering Cost, Shares | 34,000 | ||||||
Non-Cash Offering Costs [Member] | Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued for Deferred Offering Cost, Shares | 34,000 | ||||||
Shares Issued for Services #1, Consultant [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 17,646 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 30,000 | ||||||
Shares Issued for Services #2 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 50,000 | 2,000 | |||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 82,500 | $ 3,620 | |||||
Shares Issued for Services #3 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 10,000 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 12,800 | ||||||
To Investor and its Affiliate [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares Offering Costs | 110,000 | ||||||
Stock Issued During Period Value Offering Costs (in Dollars) | $ 184,800 | ||||||
Shares Issued for Services #4 [Member] | Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 50,000 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 82,500 | ||||||
Shares Issued for Services #2, Consultant [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 15,000 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 23,400 | ||||||
Expenses Incurred Related to Land Excavation and Clean Up [Member] | Director [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 15,520 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 9,529 | ||||||
Shares Issued for Services #1 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 6,466 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 14,955 | ||||||
Shares Issued for Advisory Services [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Stock Issued During Period, Shares, Issued for Services | 15,846 | ||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 30,000 | ||||||
Expire December 31, 2018 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 15,000 | ||||||
Expire November 6, 2019 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 30,000 | ||||||
Expire December 23, 2020 [Member] | |||||||
NOTE 10 - STOCKHOLDERS' EQUITY (Details) [Line Items] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 20,000 |
NOTE 10 - STOCKHOLDERS' EQUITY (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($) |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2015 |
||||
Schedule of Share-based Compensation, Stock Options, Activity [Abstract] | ||||||
Number of Shares Outstanding | 75,000 | 90,000 | ||||
Weighted Average Exercise Price Outstanding (in Dollars per share) | $ 0.41 | $ 0.34 | ||||
Weighted Average Remaining Contractual Life Outstanding | 2 years | 2 years 259 days | 3 years 36 days | |||
Aggregat Intrinsic Value Outstanding (in Dollars) | $ 16,050 | $ 82,000 | $ 10,350 | |||
Number of Shares Exercisable | [1] | 65,000 | ||||
Weighted Average Exercise Price Exercisable (in Dollars per share) | [1] | $ 0.35 | ||||
Weighted Average Remaining Contractual Life Exercisable | [1] | 2 years | ||||
Aggregat Intrinsic Value Exercisable (in Dollars) | [1] | $ 16,050 | ||||
Number of Shares Granted | 0 | 0 | ||||
Number of Shares Exercised | 0 | (15,000) | ||||
Weighted Average Exercise Price Exercised (in Dollars per share) | $ 0.01 | |||||
Number of Shares Forfeited or cancelled | (10,000) | 0 | ||||
(in Dollars per share) | $ 0.80 | |||||
Number of Shares Outstanding | 65,000 | 75,000 | ||||
Weighted Average Exercise Price Outstanding (in Dollars per share) | $ 0.35 | $ 0.41 | ||||
|
NOTE 10 - STOCKHOLDERS' EQUITY (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights |
12 Months Ended |
---|---|
Dec. 31, 2016
$ / shares
shares
| |
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract] | |
Outstanding at December 31, 2015 | shares | 1,000,000 |
Outstanding at December 31, 2015 | $ / shares | $ 3.00 |
Granted | shares | 0 |
Granted | $ / shares | $ 0 |
Exercised | shares | 0 |
Exercised | $ / shares | $ 0 |
Forfeited or cancelled | shares | 0 |
Forfeited or cancelled | $ / shares | $ 0 |
Expired | shares | 1,000,000 |
Expired | $ / shares | $ 3.00 |
Outstanding at December 31, 2016 | shares | 0 |
Outstanding at December 31, 2016 | $ / shares | $ 0 |
Exercisable at December 31, 2016 | shares | 0 |
Exercisable at December 31, 2016 | $ / shares | $ 0 |
NOTE 11 - INCOME TAXES (Details) - USD ($) |
12 Months Ended | |||
---|---|---|---|---|
Jan. 01, 2018 |
Dec. 22, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
NOTE 11 - INCOME TAXES (Details) [Line Items] | ||||
Operating Loss Carryforwards | $ 11,795,000 | $ 10,973,000 | ||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% | 34.00% | 34.00% | |
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | $ 1,425,999 | |||
Operating Loss Carryforwards, Expiration Year | 2037 | |||
Subsequent Event [Member] | ||||
NOTE 11 - INCOME TAXES (Details) [Line Items] | ||||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% |
NOTE 11 - INCOME TAXES (Details) - Schedule of Reconciliation of Income Tax Benefit - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Schedule of Reconciliation of Income Tax Benefit [Abstract] | ||
Net (Loss) | $ (1,833,728) | $ (1,785,114) |
Benefit (expense) for income taxes computed using the statutory rate of 21% and 34%, respectively | 385,083 | 606,939 |
Non-deductible expense | (212,526) | (99,086) |
Remeasurement of deferred income taxes due to tax reform | (1,425,999) | 0 |
Change in valuation allowance | 1,253,442 | (507,853) |
Provision for income taxes | $ 0 | $ 0 |
NOTE 11 - INCOME TAXES (Details) - Schedule of Reconciliation of Income Tax Benefit (Parentheticals) |
12 Months Ended | ||
---|---|---|---|
Dec. 22, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Schedule of Reconciliation of Income Tax Benefit [Abstract] | |||
Statutory rate | 21.00% | 34.00% | 34.00% |
NOTE 11 - INCOME TAXES (Details) - Schedule of Deferred Assets and Liabilities - USD ($) |
Dec. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Schedule of Deferred Assets and Liabilities [Abstract] | ||
Total deferred tax assets – net operating losses | $ 2,476,950 | $ 3,731,181 |
Deferred tax liabilities | ||
Depreciation | 0 | (789) |
Net deferred tax assets | 2,476,950 | 3,730,392 |
Valuation allowance | (2,476,950) | (3,730,392) |
$ 0 | $ 0 |
NOTE 11 - INCOME TAXES (Details) - Summary of Operating Loss Carryforwards |
Dec. 31, 2017
USD ($)
|
---|---|
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | $ 11,795,000 |
2019 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 6,166,000 |
2026 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 408,000 |
2027 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 693,000 |
2028 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 771,000 |
2029 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 197,000 |
2030 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 32,000 |
2031 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 415,000 |
2033 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 692,000 |
2034 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 106,000 |
2036 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | 1,493,000 |
(new) 2037 [Member] | |
Operating Loss Carryforwards [Line Items] | |
Operating Loss Carryforward | $ 822,000 |
NOTE 11 - INCOME TAXES (Details) - Schedule of Change in Valuation Allowance - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
|
Schedule of Change in Valuation Allowance [Abstract] | ||
Valuation Allowance | $ (2,476,950) | $ (3,730,392) |
Valuation Allowance | $ 1,253,442 |
NOTE 12 - LEASES AND COMMITMENTS (Details) - USD ($) |
7 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
May 01, 2016 |
Jul. 31, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Due to Related Parties | $ 81,058 | $ 4,000 | |||||||
Due to Related Parties, Current | 81,058 | 4,000 | |||||||
Operating Leases, Rent Expense | 46,200 | 35,300 | |||||||
Chief Executive Officer [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Officers' Compensation | $ 170,000 | 195,000 | |||||||
Employment Agreement, Bonus, Percentage of Salary | 35.00% | ||||||||
Related Party Transaction, Amounts of Transaction | 2,234 | ||||||||
Due to Related Parties | [1] | 10,000 | 4,000 | ||||||
Other Commitment, Due in Next Twelve Months | 24,000 | ||||||||
Other Commitment, Due in Second Year | 24,000 | ||||||||
Other Commitment, Due in Third Year | 24,000 | ||||||||
Chief Executive Officer [Member] | Housing and Automobile [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Related Party Transaction, Amounts of Transaction | 24,000 | 16,000 | |||||||
Due to Related Parties | 10,000 | 4,000 | |||||||
Due to Related Parties, Current | 4,000 | ||||||||
Building [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Operating Leases, Rent Expense, Minimum Rentals | 750 | ||||||||
Building [Member] | Clearwater, Florida [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 904 | ||||||||
Building [Member] | Pueblo, Colorado [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Operating Leases, Rent Expense, Minimum Rentals | $ 2,000 | ||||||||
Building [Member] | Nashville, Tennessee [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Operating Leases, Future Minimum Payments Due, Next Twelve Months | 2,500 | ||||||||
Operating Leases, Future Minimum Payments, Due in Two Years | 2,250 | ||||||||
Building [Member] | Chief Executive Officer [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Employment Agreement, Reimbursement | $ 1,000 | 1,000 | |||||||
Vehicles [Member] | Chief Executive Officer [Member] | |||||||||
NOTE 12 - LEASES AND COMMITMENTS (Details) [Line Items] | |||||||||
Employment Agreement, Reimbursement | $ 1,000 | 1,000 | |||||||
Due to Related Parties | [2] | $ 29,064 | $ 0 | ||||||
|
NOTE 12 - LEASES AND COMMITMENTS (Details) - Schedule of Future Minimum Rental Payments for Operating Leases |
Dec. 31, 2017
USD ($)
|
---|---|
NOTE 12 - LEASES AND COMMITMENTS (Details) - Schedule of Future Minimum Rental Payments for Operating Leases [Line Items] | |
2018 | $ 54,050 |
2019 | 54,600 |
Total | 108,650 |
Retail Space in Tennessee [Member] | |
NOTE 12 - LEASES AND COMMITMENTS (Details) - Schedule of Future Minimum Rental Payments for Operating Leases [Line Items] | |
2018 | 30,050 |
2019 | 30,600 |
Total | 60,650 |
Housing Allowance [Member] | |
NOTE 12 - LEASES AND COMMITMENTS (Details) - Schedule of Future Minimum Rental Payments for Operating Leases [Line Items] | |
2018 | 12,000 |
2019 | 12,000 |
Total | 24,000 |
Automobile Allowance [Member] | |
NOTE 12 - LEASES AND COMMITMENTS (Details) - Schedule of Future Minimum Rental Payments for Operating Leases [Line Items] | |
2018 | 12,000 |
2019 | 12,000 |
Total | $ 24,000 |
NOTE 14 - SUBSEQUENT EVENTS (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 30, 2018 |
Mar. 26, 2018 |
Mar. 19, 2018 |
Mar. 01, 2018 |
Feb. 28, 2018 |
Mar. 31, 2017 |
Dec. 31, 2017 |
Dec. 31, 2016 |
Jun. 30, 2017 |
Nov. 02, 2007 |
|||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 1,000,000 | |||||||||||
Common Stock, Shares Authorized | 150,000,000 | 150,000,000 | ||||||||||
Due to Related Parties (in Dollars) | $ 81,058 | $ 4,000 | ||||||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | 565,569 | $ 286,575 | ||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Director [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 82,500 | $ 99,000 | ||||||||||
Stock Issued During Period, Shares, Issued for Services | 50,000 | 60,000 | ||||||||||
Stock Issued During Period, Shares, New Issues | 130,000 | |||||||||||
Chief Executive Officer [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Due to Related Parties (in Dollars) | [1] | $ 10,000 | $ 4,000 | |||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | |||||||||||
Improving Retail Space in Tennessee [Member] | Director [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Due to Related Parties (in Dollars) | 29,064 | |||||||||||
Improving Retail Space in Tennessee, Paid After December 2017 In Shares [Member] | Director [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Stock Issued During Period, Value, Issued for Services (in Dollars) | $ 17,648 | |||||||||||
Stock Issued During Period, Shares, Issued for Services | 36,018 | |||||||||||
Subsequent Event [Member] | The 2018 Plan [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 1,000,000 | |||||||||||
Common Stock, Shares Authorized | 500,000 | |||||||||||
Subsequent Event [Member] | Maximum [Member] | The 2018 Plan [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | 5,000,000 | |||||||||||
Subsequent Event [Member] | Pursuant to Licensing Agreement [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Stock Issued During Period, Shares, New Issues | 2,000 | |||||||||||
Subsequent Event [Member] | SEC Counsel [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Stock Issued During Period, Shares, Issued for Services | 15,000 | |||||||||||
Subsequent Event [Member] | Chief Executive Officer [Member] | ||||||||||||
NOTE 14 - SUBSEQUENT EVENTS (Details) [Line Items] | ||||||||||||
Due to Related Parties (in Dollars) | $ 20,000 | $ 40,000 | $ 12,000 | |||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | 8.00% | 8.00% | |||||||||
Debt Instrument, Payment Terms | 60 days | 60 days | 60 days | |||||||||
|
^H$" @(GH2I@
M.=QA#X2H0A+C]UC3G[94QOG\M?HGW;OLY8@Y["GYU9Q%O?4+WSO#!=^(>*+#
M9QC[27UO;/XKW(%(N2*1>YPHX?K?.]VXH.U81:*T^,6,3:?'P:QDV6AS&Z+1
M$$V&,/FG(1X-L65 ADRW^A$+7)6,#AXS-ZO'ZID(-[&\F">5U-=.K\ENN
MJS0IT5W5&24[(XEFDNA1L5\JXF"2(+G_!!$Y(2+M3^80J05A))F6=%H2YDD:
M6"!+U1L1M_1YJGIO6PU'"UQO5+"_CV
M-$-&-_3=\=C6C0\.EJ>=J.$)_*_N:-%B,TO9*M"N-9I8J#)ZN]D?=B$^!OQN
M87"+,PF5G(QY#L;W,J-)$ 02"A\8!&YGN ,I Q'*>)DXZ9PR )?G=_;[6#O6
M@-)254HI?^T0P/,-5S2 DZ9HE@R+ZD2+=2G-+_X.DV?+^I%\E6/55@VSA-CE1FT'&25]YE8._3^"9_PZ=I
M_\9M*[0C%^/Q96/_&V,\H)3D!D>HPP^V&!(:'XYW>+;3F$V&-_W\@]CRCO":[([3^0/H<=+:7ZNIO9^QW]ST(__W
M0AS*I@N>N53#JADI]YQ+ICC&=ZJ<1_66,2XJMI?Z-E?WHA^U^X7D[? :$8WO
M,JM_4$L#!!0 ( "UJ@DP*(U\<+0, %H. 9 >&PO=V]R:W-H965T
M